Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Kiadis acquires research assets related to Wnt-signal transduction pathway

Jan. 25, 2007

ThermoDox phase I data suggest manageable toxicity; patient accrual continues

Jan. 25, 2007

DCA inhibits cancer growth by normalizing mitochondrial function and promoting apoptosis

Jan. 24, 2007

Pharmion files MAA for Thalidomide Pharmion for multiple myeloma

Jan. 24, 2007

Anticancer drug WBI-2100 stimulates immune system in preclinical studies

Jan. 24, 2007

FDA accepts sNDA for Doxil + Velcade in relapsed/refractory multiple myeloma

Jan. 24, 2007

Final results from the ACTS-GC trial announced

Jan. 23, 2007

Addition of bevacizumab to chemotherapy improves progression-free survival in MCRC patients

Jan. 23, 2007

No benefit of adding bevacizumab to standard therapy in pancreatic cancer

Jan. 23, 2007

Safety data from the STAR study presented

Jan. 23, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...